Format

Send to

Choose Destination
See comment in PubMed Commons below
EMBO Rep. 2008 Sep;9(9):865-71. doi: 10.1038/embor.2008.139. Epub 2008 Jul 25.

Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Author information

1
Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino, S.P. 142, 10060 Candiolo, Torino, Italy.

Abstract

The semaphorins constitute a large family of molecular signals with regulatory functions in neuronal development, angiogenesis, cancer progression and immune responses. Accumulating data indicate that semaphorins might trigger multiple signalling pathways, and mediate different and sometimes opposing effects, depending on the cellular context and the particular plexin-associated subunits of the receptor complex, which can include receptor-type or cytoplasmic tyrosine kinases such as MET, ERBB2, VEGFR2, FYN, FES, PYK2 and SRC. It has also been shown that a specific plexin can alternatively associate with different tyrosine kinase receptors, eliciting divergent signalling pathways and functional outcomes. Tyrosine phosphorylation is a pivotal post-translational protein modification that regulates intracellular signalling. Therefore, phosphorylation of tyrosines in the intracellular domain of plexins could determine or modify their interactions with additional signal transducers. Here, we discuss the potential relevance of tyrosine phosphorylation in semaphorin-induced signalling, with an emphasis on its probable role in dictating the choice between multiple pathways and functional outcomes. The identification of implicated tyrosine kinases will pave the way to target individual semaphorin-mediated functions.

PMID:
18660749
PMCID:
PMC2529352
DOI:
10.1038/embor.2008.139
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center